Company Name: Signal Genetics, Inc.      

Signal Genetics, Inc. is a molecular diagnostic company. The company’s Myeloma Prognostic Risk Signature test is designed to help physicians determine an optimal treatment plan for their multiple myeloma (MM) patients.

Ticker Symbol: SGNL (NASDAQ)

Company Website: www.signalgenetics.com

Social Media:

Signal Genetics Facebook

Signal Genetics LinkedIn Page

Headquarters: Carlsbad, CA